
The US cannabis industry is growing steadily with expanding legalization and stronger legal frameworks, boosting market size and revenues. Improved profitability and operational efficiency are attracting more investors to top marijuana stocks like Trulieve, Greenlane, and Cresco Labs. Recent moves to reschedule cannabis to Schedule III could reduce taxes and unlock institutional capital, further supporting stock gains. Investors are closely watching these companies for solid opportunities amid this evolving market.